|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
|
Keros Therapeutics, Inc. (KROS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
| |
Company
Roster
|
|
Total
Insiders : |
19 |
|
|
|
Total
Direct Shares :
|
2,624,854 |
|
|
Total
Indirect Shares :
|
14,959,567 |
| |
%
Held by Insiders:
|
6.4% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Farzan Nima |
|
2025-06-04 |
5,250 |
2025-06-04 |
0 |
| Bienaime Jean Jacques |
|
2025-06-04 |
5,450 |
|
0 |
| Gray Mary Ann |
|
2025-06-04 |
5,250 |
2025-06-04 |
0 |
| Kariv Tomer |
|
2025-06-04 |
5,250 |
2025-06-04 |
4,632,069 |
| Nussbaum Ran |
|
2025-06-04 |
5,250 |
2025-06-04 |
4,632,069 |
| Gordon Carl L |
|
2025-06-04 |
5,250 |
2025-06-04 |
1,018,734 |
| Seth Alpna |
|
2025-06-04 |
5,250 |
2025-06-04 |
0 |
| Knowles Julius |
|
2025-06-04 |
6,441 |
2025-06-04 |
574,301 |
| Schneeberger Daniel |
10% Owner |
2025-04-09 |
0 |
2025-06-20 |
743,358 |
| Seehra Jasbir |
|
2025-04-04 |
302,223 |
|
0 |
| Regnante Keith |
|
2025-02-18 |
44,000 |
2023-06-08 |
0 |
| Rovaldi Christopher |
|
2025-02-18 |
60,000 |
2022-04-01 |
0 |
| Chyung Yung H. |
|
2025-02-18 |
44,000 |
2025-02-18 |
0 |
| Lachey Jennifer |
Chief Scientific Officer |
2022-07-15 |
95,100 |
|
0 |
| Ordonez Claudia |
Chief Medical Officer |
2021-06-11 |
0 |
2021-02-11 |
0 |
| Orbimed Genesis Gp Llc |
Director |
2020-04-13 |
0 |
2024-08-13 |
119,522 |
| Lazarus Alon |
Director, 10% Owner |
2020-04-13 |
23,038 |
2020-04-13 |
2,013,102 |
| Arkin Moshe |
10% Owner |
2020-04-13 |
2,013,102 |
2020-04-13 |
0 |
| Pontifax Late Stage Gp Ltd. |
10% Owner |
|
0 |
2022-11-29 |
1,226,412 |
|
|
